Caixin
Oct 29, 2022 08:00 AM

Shenzhen Kangtai Biological Products Co.,Ltd.’s Net Profit Dropped 80.4% in First Three Quarters of 2022

00:00
00:00/00:00
Listen to this article 1x

Shenzhen Kangtai Biological Products Co.,Ltd. (深圳康泰生物制品股份有限公司) (300601.SZ) reported a net profit of 203.1 million yuan in the first three quarters of 2022, down 80.4% year-on-year.

Meanwhile, the company posted 2.6 billion yuan in revenue, up 7.9% year-on-year.

At the end of the reporting period, it had 13.9 billion yuan in total assets and 4.6 billion yuan in total liabilities, with a liability-to-asset ratio of 32.9%.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST